Form 4: Vertex Pharmaceuticals EVP and CMO, Carmen Bozic, Reports Stock Disposal
SEC Form 4 Filing
Carmen Bozic, EVP and CMO of Vertex Pharmaceuticals, reported the disposal of 3,309 shares of common stock on February 23, 2024.
Summary
- On February 23, 2024, Carmen Bozic, the EVP and CMO of Vertex Pharmaceuticals, disposed of 3,309 shares of common stock.
- The transaction was reported on a Form 4 filing with the SEC.
- Following the transaction, Bozic directly owns 36,939 shares of Vertex Pharmaceuticals common stock.
Sentiment
Score: 5
Explanation: This is a neutral disclosure of a stock transaction. The sentiment is neither positive nor negative as it simply reports a change in ownership.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. Investors often monitor these filings for insights into management's perspective on the company's stock.
Key Dates
| Date | Description |
|---|---|
| 02/23/2024 | Date of transaction: Disposal of 3,309 shares of common stock. |
| 02/27/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.